Stallion India Fluorochemicals Ltd

Stallion India Fluorochemicals Ltd

Stallion India Fluorochemicals Ltd has submitted a Monitoring Agency Report for the quarter ended September 30, 2026, regarding the utilization of proceeds of the Rights Issue. The report indicates that payments made to Pansen Engineering India Pvt Ltd are within the total estimated amount payable, but the exact scope of work and payments are not verifiable due to the absence of the full contract copy.

Stallion India Fluorochemicals Ltd

Stallion India Fluorochemicals Ltd has received a Monitoring Agency Report from CARE Ratings Limited for the quarter ended September 30, 2026, indicating a deviation from the objects of the Initial Public Offer (IPO) due to the company utilizing ₹0.40 crore from its own funds, contrary to the prospectus. The report is in line with the format prescribed by SEBI, capturing the comments of the Board of Directors, which shall be reviewed by the issuer's Management/Audit Committee before dissemination.

Stallion India Fluorochemicals Ltd

Stallion India Fluorochemicals Ltd has announced the publication of its unaudited financial results for the quarter and half year ended 30th September, 2026, as approved by the Board of Directors. The company has also announced an e-auction sale of immovable properties to recover outstanding dues from the borrower and guarantor.

Stallion India Fluorochemicals Ltd

Stallion India Fluorochemicals Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2026, which were approved by the Board of Directors. The company reported a profit of ₹ 5,559 lakhs and a total comprehensive income of ₹ 5,591 lakhs. The earnings per equity share for the quarter and half year were ₹ 0.21 and ₹ 0.181 respectively. The company's paid-up equity share capital remains unchanged at ₹ 11,608.57 lakhs.

Stallion India Fluorochemicals Ltd

Stallion India Fluorochemicals Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 13/11/2026 to consider and approve the unaudited financial results for the quarter ended 30th September, 2026.

Stallion India Fluorochemicals Ltd

Stallion India Fluorochemicals Ltd has cancelled its scheduled analyst/investor meeting on November 6, 2026, as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Stallion India Fluorochemicals Ltd

Stallion India Fluorochemicals Ltd has rescheduled its analyst/investor meeting from 3rd November to 6th November 2026.

Stallion India Fluorochemicals Ltd

Stallion India Fluorochemicals Ltd has announced an analyst/investor meeting on November 3, 2026, to discuss company matters. The meeting will be held virtually from 3:30 PM to 4:30 PM IST.

Stallion India Fluorochemicals Ltd

Stallion India Fluorochemicals Ltd has announced a schedule for an analyst/investor meeting on October 21st and 22nd, 2026, to discuss company matters with ICICI Securities, Kotak Securities, and Nuvama Wealth.

Stallion India Fluorochemicals Ltd

Stallion India Fluorochemicals Ltd has informed that the company has undergone a GST inspection and search proceeding initiated by the Maharashtra State GST officials at its registered office. The company has cooperated with the officials and provided necessary information and documents. The company has taken steps to address the observations raised by the GST authorities and has paid the tax and interest liability communicated in connection with the proceedings.

Stallion India Fluorochemicals Ltd

Stallion India Fluorochemicals Ltd submitted a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, stating that the entire holding of the company's shares are in demat form and no rematerialisation requests were received from members.

Stallion India Fluorochemicals Ltd

Stallion India Fluorochemicals Ltd has revised the format of its Analyst/Investor Meeting scheduled for 01st October, 2026, from a Group Virtual Meet to individual in-person meetings.

Stallion India Fluorochemicals Ltd

Stallion India Fluorochemicals Ltd has announced a group virtual meet with analysts and investors on October 1, 2026, at 4:00 PM IST. The meet is scheduled with Aditya Birla Sun Life Mutual Fund, OHM Capital, and Ambit Asset Management. No unpublished price-sensitive information will be discussed.

Stallion India Fluorochemicals Ltd

Stallion India Fluorochemicals Ltd has announced the closure of its trading window for all Designated Persons and their immediate relatives from October 1st, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter and half year ended September 30, 2026.

STALLION INDIA FLUOROCHEMICALS LIMITED

Stallion India Fluorocemicals Limited has informed the BSE about a change in the designation of a Non-Executive Independent Director.

STALLION INDIA FLUOROCHEMICALS LIMITED

Stallion India Fluorocemicals Limited has informed the BSE about a change in the designation of a Non-Executive Independent Director.

STALLION INDIA FLUOROCHEMICALS LIMITED

Stallion India Fluorocchemicals Limited has informed BSE about a change in the designation of a Non-Executive Independent Director.

STALLION INDIA FLUOROCHEMICALS LIMITED

STALLION INDIA FLUOROCHEMICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.

STALLION INDIA FLUOROCHEMICALS LIMITED

Stallion India Fluorocemicals Limited has informed the BSE about a change in the designation of a non-executive independent director.

STALLION INDIA FLUOROCHEMICALS LIMITED

Stallion India Fluorocchemicals Limited has informed BSE about a change in designation of a Non-Executive Independent Director.